Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJG0K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,722
Award facts
- Contract value 100% obligated
- $18,721.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,721.79 to AmerisourceBergen Drug Corp for KESIMPTA 20 MG/0.4 ML pen injectors on January 5, 2026, with completion anticipated by January 6, 2026. This firm fixed-price delivery order represents a pediatric pharmaceutical supply under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and was competitively awarded, reflecting AmerisourceBergen's established capability as a major pharmaceutical distributor for federal medical procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
KESIMPTA is a specialty pharmaceutical used to treat multiple sclerosis, positioning this delivery order within AmerisourceBergen's extensive portfolio of neurological and specialty medications supplied through the DLA Troop Support Medical global pharmaceutical support vehicle. This contract supports military healthcare systems and other federal government healthcare programs, including the Defense Health Agency and U.S. Coast Guard. The rapid completion timeline reflects the urgent nature of pharmaceutical supply delivery, consistent with AmerisourceBergen's role as a critical vendor for military and veteran healthcare systems across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FJG0K?
SPE2DR26FJG0K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FJG0K worth?
The government has obligated $18,722 on SPE2DR26FJG0K.
Is contract SPE2DR26FJG0K an order under another contract?
Yes. SPE2DR26FJG0K is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJG0K competed?
The extent of competition for SPE2DR26FJG0K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award